Sunchem
United States · Deep tech & materials · Pre-seed
BILIX
South Korea · Biotech & life sciences · Series A
Why talk
- Sunchem likely needs funding for the next round — BILIX (South Korea, Series A, $13M raised) can offer investor introductions (inferred from public profile).
- Complementary sectors: Deep tech & materials × Biotech & life sciences — room for a joint offer or co-selling.
- BILIX has raised about $13M — investor introductions are realistic.
Score by goal: All goals 46 · Market entry 41 · Customers 34 · Investment 64 · Peers 40
Dimension by dimension
Needs ↔ offers
17.5 / 35 pts
BILIX can help Sunchem.
- Sunchem likely needs funding for the next round — BILIX (South Korea, Series A, $13M raised) can offer investor introductions (inferred from public profile).
Market bridge
6.3 / 25 pts
Distant markets.
- BILIX is based in South Korea (Asia): a landing pad on another continent, both ways.
Customer potential
0.0 / 15 pts
Neither side has a product on the market yet.
Sector synergy
12.8 / 15 pts
Complementary sectors.
- Complementary sectors: Deep tech & materials × Biotech & life sciences — room for a joint offer or co-selling.
Stage complementarity
9.0 / 10 pts
Strong mentoring / investor-intro potential.
- BILIX has raised about $13M — investor introductions are realistic.
- BILIX (Series A) is well ahead of Sunchem (Pre-seed): mentoring and investor intros.
How the score works
Each dimension gives a value between 0 and 1, multiplied by its weight; the compatibility is the sum (0–100). Weights for “All goals”: Needs ↔ offers 35, Market bridge 25, Customer potential 15, Sector synergy 15, Stage complementarity 10. Declared needs and offers count fully; when a startup has declared nothing, a few needs/offers are inferred from its public profile (for example, no known traction ⇒ needs customers) and count at half value.
Potential blends compatibility (65%) with the mean global score of both startups (35%): 47/100 — high from 50, medium from 36.